Bosh sahifa4DX • ASX
add
4DMedical Ltd
Yopilish kursi
0,53 $
Kunlik diapazon
0,52 $ - 0,54 $
Yillik diapazon
0,41 $ - 1,10 $
Bozor kapitalizatsiyasi
219,63 mln AUD
Oʻrtacha hajm
1,00 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
ASX
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(AUD) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 1,48 mln | 1 172,70% |
Joriy xarajat | 12,56 mln | 11,42% |
Sof foyda | -10,19 mln | -33,78% |
Sof foyda marjasi | -687,84 | 89,49% |
Har bir ulushga tushum | — | — |
EBITDA | -11,09 mln | -5,51% |
Amaldagi soliq stavkasi | -0,01% | — |
Balans
Jami aktivlari
Jami passivlari
(AUD) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 30,61 mln | -56,01% |
Jami aktivlari | 120,02 mln | 29,16% |
Jami passivlari | 49,09 mln | 128,71% |
Umumiy kapital | 70,93 mln | — |
Tarqatilgan aksiyalar | 410,53 mln | — |
Narxi/balansdagi bahosi | 3,12 | — |
Aktivlardan daromad | -23,28% | — |
Kapitaldan daromad | -36,73% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(AUD) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -10,19 mln | -33,78% |
Operatsiyalardan naqd pul | -8,06 mln | 8,54% |
Sarmoyadan naqd pul | -339,48 ming | -21,29% |
Moliyadan naqd pul | -233,98 ming | -101,11% |
Naqd pulning sof oʻzgarishi | -8,64 mln | -172,48% |
Boʻsh pul | -5,43 mln | 13,25% |
Haqida
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Tashkil etilgan
2013
Sayt
Xodimlar soni
145